CSIMarket
 
Effector Therapeutics Inc   (NASDAQ: EFTR)
 

Effector Therapeutics Inc's Customers Performance

EFTR



 
EFTR's Source of Revenues

List of EFTR Customers




for the same period Effector Therapeutics Inc

List of EFTR Customers





Effector Therapeutics Inc's Comment on Sales, Marketing and Customers





  News about Effector Therapeutics Inc Contracts

eFFECTOR Therapeutics' Zotatifin: A Breakthrough in Breast Cancer Treatment



In recent news, eFFECTOR Therapeutics, a leading biopharmaceutical company, has announced positive interim data from its dose escalation and Phase 2 expansion cohorts of Zotatifin in ER+ metastatic breast cancer patients. The study evaluated the combination of Zotatifin with fulvestrant and abemaciclib in heavily pretreated patients, demonstrating a median progression-free survival of 7.4 months. This article aims to outline the key facts and assess the impact of these findings on eFFECTOR Therapeutics Inc.

eFFECTOR Therapeutics Inc., a renowned biopharmaceutical company specializing in targeted cancer therapies, has revealed promising results from the ongoing evaluation of Zotatifin. In p...












EFTR's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Effector Therapeutics Inc 0.00 0.00 -34.63 47
SUBTOTAL 0.00 0.00 0.00 -

Sources: Effector Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Effector Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Effector Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.